Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Fortium Holdings Corp. | mntm_ex32z1.htm |
| EX-31.2 - EXHIBIT 31.2 - Fortium Holdings Corp. | mntm_ex31z2.htm |
| EX-31.1 - EXHIBIT 31.1 - Fortium Holdings Corp. | mntm_ex31z1.htm |
| EX-10.14 - EXHIBIT 10.14 - Fortium Holdings Corp. | mntm_ex10z14.htm |
| EX-10.13 - EXHIBIT 10.13 - Fortium Holdings Corp. | mntm_ex10z13.htm |
| EX-10.12 - EXHIBIT 10.12 - Fortium Holdings Corp. | mntm_ex10z12.htm |
| 10-K - 10-K - Fortium Holdings Corp. | mntm_10k.htm |
Exhibit 32.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned, James P. Stapleton, Chief Financial Officer of Mount Tam Biotechnologies, Inc. (the "Company") hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)the Report on Form 10-K of the Company for the year ended December 31, 2017 (the "Report") fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: April 10, 2018 | By: | /s/ James P. Stapleton |
| Name: | James P. Stapleton |
| Title: | Chief Financial Officer |
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.